Kennedy Keith 4
4 · VERACYTE, INC. · Filed Jul 7, 2020
Insider Transaction Report
Form 4
VERACYTE, INC.VCYT
Kennedy Keith
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2020-07-02$5.98/sh+2,800$16,744→ 158,398 total - Exercise/Conversion
Common Stock
2020-07-06$5.98/sh+10,075$60,249→ 162,726 total - Exercise/Conversion
Common Stock
2020-07-06$9.05/sh+15,416$139,515→ 200,309 total - Exercise/Conversion
Stock Option (right to buy)
2020-07-06−22,167→ 22,223 totalExercise: $7.47Exp: 2026-12-05→ Common Stock (22,167 underlying) - Sale
Common Stock
2020-07-02$28.02/sh−5,747$161,040→ 152,651 total - Exercise/Conversion
Common Stock
2020-07-06$7.47/sh+22,167$165,587→ 184,893 total - Sale
Common Stock
2020-07-06$28.21/sh−80,677$2,276,172→ 119,632 total - Exercise/Conversion
Stock Option (right to buy)
2020-07-02−2,800→ 47,092 totalExercise: $5.98Exp: 2028-03-01→ Common Stock (2,800 underlying) - Exercise/Conversion
Stock Option (right to buy)
2020-07-06−10,075→ 37,017 totalExercise: $5.98Exp: 2028-03-01→ Common Stock (10,075 underlying) - Exercise/Conversion
Stock Option (right to buy)
2020-07-06−15,416→ 4,584 totalExercise: $9.05Exp: 2027-03-02→ Common Stock (15,416 underlying)
Footnotes (6)
- [F1]The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 11, 2020.
- [F2]Represents weighted average sales price. Sale prices for the transactions range from $28.00 to $28.15. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
- [F3]Represents weighted average sales price. Sale prices for the transactions range from $28.00 to $28.58. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
- [F4]The option becomes exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.
- [F5]The option began to vest on December 6, 2017 and vests at a rate of 1/36th per total number of shares subject to the award each month, subject to the continuing employment of the reporting person on the vesting date.
- [F6]The option becomes exercisable as to 25% of the shares on March 3, 2018, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.